ProQR Therapeutics N.V (PRQR) Amortization - Deferred Charges: 2021-2025
- ProQR Therapeutics N.V's Amortization - Deferred Charges rose 71.52% to -$157,342 in Q2 2025 from the same period last year, while for Jun 2025 it was -$1.8 million, marking a year-over-year decrease of 364.29%. This contributed to the annual value of $3.3 million for FY2021, which is 22.21% down from last year.
- ProQR Therapeutics N.V's Amortization - Deferred Charges amounted to -$157,342 in Q2 2025, which was up 70.55% from -$534,357 recorded in Q1 2025.
- In the past 5 years, ProQR Therapeutics N.V's Amortization - Deferred Charges registered a high of $1.4 million during Q1 2022, and its lowest value of -$552,443 during Q2 2024.
- Moreover, its 2-year median value for Amortization - Deferred Charges was -$532,251 (2024), whereas its average is -$443,572.
- In the last 5 years, ProQR Therapeutics N.V's Amortization - Deferred Charges spiked by 299.81% in 2022 and then decreased by 0.79% in 2025.
- ProQR Therapeutics N.V's Amortization - Deferred Charges (Quarterly) stood at $340,903 in 2021, then spiked by 299.81% to $1.4 million in 2022, then reached -$552,443 in 2024, then surged by 71.52% to -$157,342 in 2025.
- Its last three reported values are -$157,342 in Q2 2025, -$534,357 for Q1 2025, and -$552,443 during Q2 2024.
